BMY: Bristol-Myers Squibb Company

BMY News

• Zacks 14:54 Will Reblozyl Enable BMY to Offset the Impact of Generic Competition?
• Zacks 14:25 Will Keytruda Continue to Aid MRK's Top Line Ahead of Q2 Earnings?
• Zacks 14:14 Here's What to Expect From Pfizer's Non-Oncology Drugs in Q2 Earnings
• Zacks 21:45 Bristol Myers Squibb (BMY) Outperforms Broader Market: What You Need to Know
• Benzinga 18:15 Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US - AstraZeneca (NASDAQ:AZN)
• Investor's Business Daily 17:29 Why Replimune's Surprise Rejection Rattled Wall Street, And Cratered Its Stock
• Zacks 15:51 JNJ Seeks FDA Approval for Oral Psoriasis Drug Icotrokinra
• Benzinga 13:41 FDA Rejects Replimune's Blood Cancer Drug, Stock Sinks - Replimune Group (NASDAQ:REPL)
• Zacks 13:10 3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
• Investing 12:53 Truist Securities initiates Disc Medicine stock with Buy rating, $86 target
• Benzinga 11:46 Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields - AbbVie (NYSE:ABBV), Bristol-Myers Squibb (NYSE:BMY)
• Investing 11:05 FDA accepts Bristol Myers Squibb’s application for Sotyktu in psoriatic arthritis
• Investing 09:49 The FOUR standout AI-picked wins are up a massive 100%+ now
• Investing 20:55 Disc medicine CFO Franchi sells $119k in shares
• Seeking Alpha 18:46 July's 5 Dividend Growth Stocks With Yields Up To 7.96%
• Benzinga 17:54 Bristol Myers' Drug Flunks Blood Cancer-Associated Anemia Trial - Bristol-Myers Squibb (NYSE:BMY)
• Investing 14:31 Raymond James reiterates Strong Buy on Disc Medicine stock amid Bristol Myers trial results
• Investing 14:10 Bristol-Myers Squibb stock holds steady as Reblozyl study misses endpoint
• Zacks 13:00 Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
• Investing 11:04 Bristol Myers Squibb’s Reblozyl misses primary endpoint in myelofibrosis trial
• Seeking Alpha 10:40 The Davenport Insider Buying Fund Q2 2025 Commentary (DBUYX)
• Seeking Alpha 10:35 The Davenport Balanced Fund Q2 2025 Commentary (DBALX)
• Seeking Alpha 10:15 The Davenport Value & Income Fund Q2 2025 Commentary (undefined:DVIPX)
• Benzinga 18:55 Bristol‑Myers Squibb, Pfizer Set To Launch Direct‑To‑Patient Eliquis At 40% Off - Pfizer (NYSE:PFE), Bristol-Myers Squibb (NYSE:BMY)